Concerning the differential expression of KL‐6 in BAL and serum across different subgroups of ILDs, our findings confirmed the potential of this biomarker in discriminating between fibrotic and non‐fibrotic‐ILDs, especially considering the significantly lower values reported in the sarcoidosis patients. The gene discussed is MUC1; the disease is sarcoidosis.